Discover 214 paid clinical trials in Bellingham, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 214
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Location: Burlington WA, Portland OR, Sacramento CA,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07440225
Phase2, Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Surrey, Bellevue WA, Draper UT, Glendale CA,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase2, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: New Westminster, Surrey, North Vancouver, Tacoma WA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: New Westminster, Seattle WA, Calgary, Las Vegas NV,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
for
Primary Biliary Cholangitis
Location: Vancouver, Seattle WA, Calgary, Sacramento CA,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06447168
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Vancouver, Edmonds WA, Seattle WA, Vancouver WA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Vancouver, Seattle WA, Salt Lake City UT, Phoenix AZ,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase3, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis